BioTools Innovator 2021 Capstone Event & Finals Competition


Welcome to the BioTools Innovator 2021 Capstone Event & Finals Competition. The event begins with presentations from senior leadership at Thermo Fisher Scientific followed by panel discussions with the 10 best-in-class startups in this year’s cohort. The day concludes with the Finals competition and crowning of the $200,000 Grand Prize Winner, selected by the live audience vote.

AGENDA

2:00 PM PT / 5 PM ET: Welcome & Keynote (Innovation at Thermo Fisher Scientific)

  • Kathryn Zavala, Managing Director, BioTools Innovator
  • Shaun Kirkpatrick, President, Biotechnologies, Research Corporation Technologies
  • Amy Butler, President Biosciences Division, Thermo Fisher Scientific
  • Lalit Dhir, VP, Strategy, Portfolio & Business Development, Thermo Fisher Scientific

2:20 PM PT / 5:20 PM ET: Showcase Panel I

  • Moderator: Matt Baker, Senior Director, Strategy and Business Development, Thermo Fisher Scientific
  • Benjamin Yellen, CEO, Celldom
  • Sridhar Iyengar, CEO, Elemental Machines
  • Josh Yang, Co-Counder & CEO, Glyphic Bio
  • Jered Haun, CEO, Kino Discovery
  • Mirko Stange, CEO, lino Biotech

3:00 PM PT / 6:00 PM ET: Showcase Panel II

  • Moderator: Bryan Poltilove, Managing Director, BroadOak Capital Partners
  • James West, CEO, Clara Biotech
  • Bernhard Suter, Managing Director, Stellate DNA
  • Dong Wang, Co-Founder & COO, Enrich Therapeutics
  • Martis Cowles, Chief Business Officer, Epicypher
  • David Marash, Co-Founder & CEO, Machine Bio

3:50 PM PT / 6:50 PM ET: Finals Competition 

Emcee: Paul Grand, Founder & CEO, MedTech Innovator

Finalists:

  • Celldom – developing a technology that enables the paired analysis of phenotypic and genomic heterogeneity in large populations of cells.
  • Clara Biotech – developing an exosome isolation platform enabling next generation biotechnology.
  • EpiCypher – developing a multiomic assay that quantitatively maps DNA methylation and chromatin elements for drug discovery.
  • Glyphic Biotechnologies – developing a single-molecule, massively parallel, de novo protein sequencing platform.
  • Machine Bio – developing the Transmembrane Protein Synthesis Platform, a technology that can produce pure protein in hours.

Guest Judges:

  • Bill Snider, Partner, BroadOak Capital Partners
  • Bryan Poltilove, Managing Director, BroadOak Capital Partners
  • Chad Souvignier, Vice President, Research Corporation Technologies
  • Shaun Kirkpatrick, President, Biotechnologies, Research Corporation Technologies

Download the Program Book with 1-page profiles on each of the presenting companies here.

Best Video Competition

Watch the following 1 minute videos from each of our 10 Accelerator companies. These were also the basis for the $5,000 Best Video Award competition.